Background | Intravenous daratumumab for treatment of patients with multiple myeloma involves a lengthy infusion that affects quality of life, and...
Day: 26 June 2020
GNS Healthcare Launches In Silico Multiple Myeloma “Patient”
GNS Healthcare, a precision medicine company leveraging artificial intelligence to model individual patients’ response to drug treatment, have...